NEW YORK — Bristol Myers Squibb Co was sued for $6.4 billion on Thursday for allegedly delaying its Breyanzi cancer drug to avoid payments to shareholders of the former Celgene Corp, which the drugmaker bought in 2019. According to a …
NEW YORK — Novartis AG agreed to pay $678 million to settle a civil fraud lawsuit brought by the U.S. government accusing the Swiss drugmaker of paying millions of dollars in kickbacks to doctors to induce them to prescribe its …
Shaun Thaxter, the former chief executive of drugmaker Indivior Plc, pleaded guilty on Tuesday to a criminal charge arising out of a U.S. Justice Department investigation into the marketing of its opioid addiction treatment Suboxone. Thaxter pleaded guilty in federal …
Purdue Pharma LP’s deal to escape thousands of lawsuits over its role in the U.S. opioid crisis may provide less than half the $10 billion that the closely held drugmaker projected in its Chapter 11 filing, said three people familiar …
The Sackler family — once known as global philanthropists backed by a fortune made from opioids and other drugs — may lose most of their wealth if they agree to an $11.5 billion settlement to resolve lawsuits against them and …
A doctor who was an early evangelist for increased use of highly addictive opioids like OxyContin to treat chronic pain — and who was paid to promote the idea — has switched sides and now says drug makers helped to …
The billionaire family that owns Purdue Pharma LP says Massachusetts officials can’t prove that it or other directors masterminded the alleged illegal marketing of the company’s OxyContin painkiller. Massachusetts Attorney General Maura Healey’s lawsuit, seeking to hold the Sacklers and …
NEW YORK — Novartis AG must face a U.S. government lawsuit accusing it of paying millions of dollars in kickbacks to doctors so they would prescribe its drugs, after a federal judge ruled in a decision released on Monday that …